Therapeutic control of leishmaniasis by inhibitors of the mammalian target of rapamycin.
Leishmaniasis is a serious global health problem affecting many people worldwide. While patients with leishmaniasis can be treated with several agents, drug toxicicty and the emergence of resistant strains render available treatments ineffective in the long run. Inhibitors of the mammalian target of...
Main Authors: | Fatemeh Khadir, Christopher R Shaler, Ahmad Oryan, Patrick T Rudak, Delfina M Mazzuca, Tahereh Taheri, Jimmy D Dikeakos, S M Mansour Haeryfar, Sima Rafati |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-08-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC6122837?pdf=render |
Similar Items
-
Live vaccination tactics: possible approaches for controlling visceral leishmaniasis
by: Noushin eSaljoughian, et al.
Published: (2014-03-01) -
Rapamycin activates mammalian microautophagy
by: Masahiro Sato, et al.
Published: (2019-06-01) -
The regulation of mammalian target of rapamycin
by: Xie, Jianling
Published: (2012) -
Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis
by: Won Seop Kim
Published: (2011-06-01) -
Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer
by: Zhan You-qing, et al.
Published: (2010-10-01)